
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 40
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 22
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 22
The ouroboros of autoimmunity
Jean‐Laurent Casanova, Jessica N. Peel, Jean Donadieu, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 743-754
Closed Access | Times Cited: 16
Jean‐Laurent Casanova, Jessica N. Peel, Jean Donadieu, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 743-754
Closed Access | Times Cited: 16
Aire in Autoimmunity
Corey N. Miller, Michael Waterfield, James M. Gardner, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 427-53
Closed Access | Times Cited: 8
Corey N. Miller, Michael Waterfield, James M. Gardner, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 427-53
Closed Access | Times Cited: 8
The Microbe, the Infection Enigma, and the Host
Jean‐Laurent Casanova, Laurent Abel
Annual Review of Microbiology (2024) Vol. 78, Iss. 1, pp. 103-124
Closed Access | Times Cited: 8
Jean‐Laurent Casanova, Laurent Abel
Annual Review of Microbiology (2024) Vol. 78, Iss. 1, pp. 103-124
Closed Access | Times Cited: 8
Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease
Charles E. Samuel
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 104960-104960
Open Access | Times Cited: 20
Charles E. Samuel
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 104960-104960
Open Access | Times Cited: 20
Human determinants of age-dependent patterns of death from infection
Laurent Abel, Jean‐Laurent Casanova
Immunity (2024) Vol. 57, Iss. 7, pp. 1457-1465
Open Access | Times Cited: 4
Laurent Abel, Jean‐Laurent Casanova
Immunity (2024) Vol. 57, Iss. 7, pp. 1457-1465
Open Access | Times Cited: 4
From second thoughts on the germ theory to a full-blown host theory
Jean‐Laurent Casanova
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 26
Open Access | Times Cited: 11
Jean‐Laurent Casanova
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 26
Open Access | Times Cited: 11
Type I interferon pathway genetic variants in severe COVID-19
Artur Fontenelle Lima Montenegro, Marco Clementino, Juliana Navarro Ueda Yaochite
Virus Research (2024) Vol. 342, pp. 199339-199339
Open Access | Times Cited: 3
Artur Fontenelle Lima Montenegro, Marco Clementino, Juliana Navarro Ueda Yaochite
Virus Research (2024) Vol. 342, pp. 199339-199339
Open Access | Times Cited: 3
Yin and yang of interferons: lessons from the coronavirus disease 2019 (COVID-19) pandemic
Sara Svensson Akusjärvi, Ivan Zanoni
Current Opinion in Immunology (2024) Vol. 87, pp. 102423-102423
Closed Access | Times Cited: 3
Sara Svensson Akusjärvi, Ivan Zanoni
Current Opinion in Immunology (2024) Vol. 87, pp. 102423-102423
Closed Access | Times Cited: 3
Inherited human RelB deficiency impairs innate and adaptive immunity to infection
Tom Le Voyer, Majistor Raj Luxman Maglorius Renkilaraj, Kunihiko Moriya, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 3
Tom Le Voyer, Majistor Raj Luxman Maglorius Renkilaraj, Kunihiko Moriya, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 3
Improving Access to Therapy for Patients With Inborn Errors of Immunity: A Call to Action
Morna J. Dorsey, Antônio Condino‐Neto
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 6, pp. 1698-1702
Closed Access | Times Cited: 8
Morna J. Dorsey, Antônio Condino‐Neto
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 6, pp. 1698-1702
Closed Access | Times Cited: 8
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients
Ami Aoki, Chiaki Iwamura, Masahiro Kiuchi, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 4
Open Access | Times Cited: 2
Ami Aoki, Chiaki Iwamura, Masahiro Kiuchi, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 4
Open Access | Times Cited: 2
In search of a function for human type III interferons: insights from inherited and acquired deficits
Qian Zhang, Kai Kisand, Yi Feng, et al.
Current Opinion in Immunology (2024) Vol. 87, pp. 102427-102427
Closed Access | Times Cited: 2
Qian Zhang, Kai Kisand, Yi Feng, et al.
Current Opinion in Immunology (2024) Vol. 87, pp. 102427-102427
Closed Access | Times Cited: 2
A sensitive assay for measuring whole-blood responses to type I IFNs
Adrian Gervais, C Floch, Tom Le Voyer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 40
Open Access | Times Cited: 2
Adrian Gervais, C Floch, Tom Le Voyer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 40
Open Access | Times Cited: 2
Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis
Abolfazl Akbari, Alireza Hadizadeh, Mahdi Amiri, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100219-100219
Open Access | Times Cited: 7
Abolfazl Akbari, Alireza Hadizadeh, Mahdi Amiri, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100219-100219
Open Access | Times Cited: 7
Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
Romain Lévy, Agathe Escudier, Paul Bastard, et al.
Journal of Clinical Immunology (2023) Vol. 44, Iss. 1
Open Access | Times Cited: 7
Romain Lévy, Agathe Escudier, Paul Bastard, et al.
Journal of Clinical Immunology (2023) Vol. 44, Iss. 1
Open Access | Times Cited: 7
The zebrafish as a potential model for vaccine and adjuvant development
Peter J. Hotez, María Elena Bottazzi, Nelufa Islam, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 535-545
Open Access | Times Cited: 2
Peter J. Hotez, María Elena Bottazzi, Nelufa Islam, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 535-545
Open Access | Times Cited: 2
The role of interferon in the thymus
Ryan J. Martinez, Kristin A. Hogquist
Current Opinion in Immunology (2023) Vol. 84, pp. 102389-102389
Open Access | Times Cited: 6
Ryan J. Martinez, Kristin A. Hogquist
Current Opinion in Immunology (2023) Vol. 84, pp. 102389-102389
Open Access | Times Cited: 6
A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1
Bergithe E Oftedal, Amund Holte Berger, Øyvind Bruserud, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access | Times Cited: 6
Bergithe E Oftedal, Amund Holte Berger, Øyvind Bruserud, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access | Times Cited: 6
Anti-influenza A virus restriction factors that shape the human species barrier and virus evolution
Philipp P. Petric, Martin Schwemmle, Laura Graf
PLoS Pathogens (2023) Vol. 19, Iss. 7, pp. e1011450-e1011450
Open Access | Times Cited: 5
Philipp P. Petric, Martin Schwemmle, Laura Graf
PLoS Pathogens (2023) Vol. 19, Iss. 7, pp. e1011450-e1011450
Open Access | Times Cited: 5
Inborn errors of immunity illuminate mechanisms of human immunology and pave the road to precision medicine
Elena W.Y. Hsieh, Alexandre Bolze, Joseph D. Hernandez
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 5-14
Open Access | Times Cited: 1
Elena W.Y. Hsieh, Alexandre Bolze, Joseph D. Hernandez
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 5-14
Open Access | Times Cited: 1
MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients
Amit K. Maiti
Clinical Reviews in Allergy & Immunology (2024)
Closed Access | Times Cited: 1
Amit K. Maiti
Clinical Reviews in Allergy & Immunology (2024)
Closed Access | Times Cited: 1
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection
Arianna Romani, Domenico Sergi, Enrico Zauli, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 4
Arianna Romani, Domenico Sergi, Enrico Zauli, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 4
COVID-19. Biology, pathophysiology, and immunology: a pathologist view
Marco Chilosi, Claudio Doglioni, Claudia Ravaglia, et al.
Pathologica (2023) Vol. 115, Iss. 5, pp. 248-256
Open Access | Times Cited: 2
Marco Chilosi, Claudio Doglioni, Claudia Ravaglia, et al.
Pathologica (2023) Vol. 115, Iss. 5, pp. 248-256
Open Access | Times Cited: 2